reports
Ford Equity International Rating and Forecast Report
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
- Christophe DOMBU
Proprietary products to drive Diaxonhit’s growth in 2016
Diaxonhit is a company developing, producing, and marketing in vitro diagnostic (IVD) tests. Diaxonhit’s expertise in IVD development resides in genomics and proteomics technologies. The company has a dual business model comprised of the distribution of a wide range of IVD tests in France, Belgium and Switzerland through its Ingen subsidiary, and with the development of innovative IVD tests. The company has generated a well-balanced portfolio of proprietary products and licensed IVD tests (Fig...
New opportunities for extended use of Allomap in heart transplant reje...
Diaxonhit reported positive results from the CARGO II clinical study for Allomap, a blood test used for heart transplant reÄ´jection monitoring. The study, conducted on European paÄ´tients, demonstrated similar results obtained in the previous CARGO I study, performed in the US. Last April, during a symÄ´posium organized by CareDx and Diaxonhit, interesting data were presented regarding new opportunities for extended use of the Allomap test: a correlation between the Allomap score and patient lo...
Diaxonhit to launch its first proprietary product with BJI InoPlex CE ...
​Diaxonhit announced last November, positive results for the BJI InoPlex validation study, intended for the diagnosis of prosthetic joint infections (PJI). There are more than 3 million total hip and knee replacements performed every year in Europe and the US and this number is expected to grow with aging populations. As much as 20% of patients complain of pain following surgery. It is therefore crucial to identify early if it originates from PJI, an uncommon but serious complication. Bacteria...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.